GC patients with EBV-positive tumors exhibit a higher amount of immune checkpoint genes such as PD-1 or CTLA-4 and a higher level of lymphocytic infiltration compared to MSS (microsatellite stable) tumors [44]. The gene discussed is PDCD1; the disease is gastric cancer.